Company intelligence / Profile preview

FIBO

Amsterdam, North Holland, Netherlands

Ownership: Private
Development stage: Other

Overview

FiBo Biotech is a European B2B supplier of cannabis-derived wellness products, focused on wholesale distribution to retailers and distributors. The company markets products including vapes, gummies, and white-label cannabis offerings, and emphasizes lab testing, product consistency, regulatory compliance, and supply reliability. Its business appears to be commercial rather than drug-development oriented, with no disclosed clinical pipeline or therapeutic development programs. The company presents itself as a premium supplier serving licensed businesses and offering dedicated account management and logistics support.

Therapeutic areas: PsychiatryOther
Modalities: Small moleculeDevice
Industry: Food & Nutrition

Beyond the preview

Go deeper on FIBO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on FIBO.

Explore the full profile